FMD differs from traditional fasting in that it allows for a controlled intake of certain nutrients, providing the body with essential vitamins, minerals, and other ... Aug 17
STP125G is a single-stranded siRNA therapeutics targeting ApoC3 mRNA, based on Sirnaomics proprietary GalAheadTM mxRNA technology.... Jul 24
As the ZM008-001 clinical trial progresses, the medical community eagerly awaits the results, which could lead the way for a new era in cancer ... Jun 13
here is a clear demand for a mid-sized, agile and responsive CRO with an in-house regulatory affairs team and a proven track record ... Jun 04
Continued research and development in this area are essential to realizing the full potential of RNA-based vaccines in advancing public health and disease prevention ... Apr 17
Lungershausen said Avance Clinical is focussed on accelerating drug development for its biotech clients, from preclinical stages through to Phase III.... Mar 29
By unraveling the role of neurotransmitter-producing bacteria, particularly serotonin, in shaping immune responses, the study offers invaluable insights into preventive healthcare strategies.... Mar 18
The discovery of nasal immunotherapy with anti-CD3 as a potential treatment for Alzheimer's disease represents a ray of hope for the millions of ... Sep 15
In a groundbreaking medical breakthrough, a new cancer drug has emerged, inspired by the courage and resilience of a 9-year-old girl. This promising ... Aug 03
1 out of 3,500 boys will be affected by Duchenne muscular dystrophy (DMD), a rare genetic disorder that can get fatal. Affordable and accessible ... Jul 26
Latest pharma news update... Feb 21
Latest Corporate News update ; Pharma... Feb 14
Latest pharma news updates... Nov 12
Latest pharma news update... Oct 23
... Oct 20
Latest Pharma News update... Sep 03
Latest Pharma Update... Aug 23
Latest Pharma News Update... Aug 10
Latest Pharma News Update... Aug 07
Latest Pharma Update... Jul 30
Lecanemab is indicated for the treatment of Alzheimer’s Disease... Jun 26
Trial will evaluate potential of next generation of influenza vaccines with combined mRNA technology and flu vaccine development expertise... Jun 22
With this collaboration GSK is uniquely positioned with access to antibodies that synergistically target all three known CD226 checkpoints - TIGIT, CD96 and PVRIG.... Jun 14
MiNA will utilize its saRNA platform to research up to five targets selected by Lilly that aim to address diseases across Lilly's key therapeutic ... May 15
The third wave of the coronavirus pandemic needs to be avoided completely. The FDA looks all set to take care of children worldwide during this ... May 11
-Advertisements-
.jpeg)
Tuesday, November 26, 2024
.png)
.png)
.png)
.png)
.png)